FDA Orange Book · active-ingredient family
Cisapride monohydrate
Cisapride monohydrate is approved in 3 FDA applications, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.
Reference-listed drug:PROPULSID QUICKSOLV · NDA 020767
3
Brand (NDA)
0
Generics (ANDA)
0
Listed patents
0
Exclusivity periods
Brand (NDA) products · suspension, tablet, tablet, orally disintegrating
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| PROPULSID QUICKSOLV | JANSSEN PHARMA | NDA 020767 | — | Nov 07, 1997 | |
| PROPULSID | JANSSEN PHARMS | NDA 020398 | — | Sep 15, 1995 | |
| PROPULSID×2 | JANSSEN PHARMS | NDA 020210 | — | Jul 29, 1993 |
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Cisapride monohydrate — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

